Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Bullboard Posts
Comment by fouremmon Feb 21, 2015 3:45pm
130 Views
Post# 23451529

RE:RE:RE:RE:RE:INTERESTING ARTICLE RE cholesterol EFFLUX AS MEASURE OF HDL

RE:RE:RE:RE:RE:INTERESTING ARTICLE RE cholesterol EFFLUX AS MEASURE OF HDL Hi GV, essentially what this means is that through the process of cholesterol eflux, a greater number associted with this biomarker indicates that more choesterol efflux is taking place.  When it is "inversely associated with the incidence of cardiovascular events" it means that as more cholesterol efflux takes place (a bigger biomarker number) that fewer cardiovascular events are found to be taking place.  This is a good thing for us.

Although I have a science background, there are posters here who have a much stronger background than I do.  If I am incorrect in any part of what I have said I would hope that one of these people would correct me or add more detail where it is warranted.
Bullboard Posts